|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-7-17
|
|
pubmed:abstractText |
We investigated whether serum concentration of carboxy-terminal propeptide of procollagen type I (PIP), a marker of collagen type I synthesis, can be used to assess the ability of antihypertensive treatment to regress myocardial fibrosis in hypertensive patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amlodipine,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Procollagen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2,
http://linkedlifedata.com/resource/pubmed/chemical/procollagen type I carboxy...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
17
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
286-91
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11457746-Adult,
pubmed-meshheading:11457746-Aged,
pubmed-meshheading:11457746-Amlodipine,
pubmed-meshheading:11457746-Angiotensin Receptor Antagonists,
pubmed-meshheading:11457746-Antihypertensive Agents,
pubmed-meshheading:11457746-Biopsy,
pubmed-meshheading:11457746-Blood Pressure,
pubmed-meshheading:11457746-Collagen,
pubmed-meshheading:11457746-Endomyocardial Fibrosis,
pubmed-meshheading:11457746-European Continental Ancestry Group,
pubmed-meshheading:11457746-Female,
pubmed-meshheading:11457746-Heart,
pubmed-meshheading:11457746-Humans,
pubmed-meshheading:11457746-Hypertension,
pubmed-meshheading:11457746-Losartan,
pubmed-meshheading:11457746-Male,
pubmed-meshheading:11457746-Middle Aged,
pubmed-meshheading:11457746-Myocardium,
pubmed-meshheading:11457746-Patient Compliance,
pubmed-meshheading:11457746-Peptide Fragments,
pubmed-meshheading:11457746-Predictive Value of Tests,
pubmed-meshheading:11457746-Procollagen,
pubmed-meshheading:11457746-Receptor, Angiotensin, Type 1,
pubmed-meshheading:11457746-Receptor, Angiotensin, Type 2,
pubmed-meshheading:11457746-Remission Induction,
pubmed-meshheading:11457746-Treatment Outcome,
pubmed-meshheading:11457746-Ventricular Function, Left
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.
|
|
pubmed:affiliation |
Division of Cardiovascular Pathophysiology, School of Medicine, University of Navarra, Pamplona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
